Free tool
Healthcare stocks
We cover 86 companies in the Healthcare sector. The median market value in the group is $1.23B. Across the group, the median move over the past trading day is 0.00%. 94% of the 81 with a 200-day average trade above it. Price change over the past year runs from −19.2% to +324.0% across the middle 80 percent of the group, with a median of +61.6%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
86 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| MRCK34.SA | Merck & Co., Inc. | $388.60B | Mega cap | +81.07% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| AMGN34.SA | Amgen Inc. | $239.09B | Mega cap | +47.79% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | $231.47B | Mega cap | +22.22% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| A2LC34.SA | Alcon Inc. | $3.57B | Mid cap | −12.15% |
| PLSE | Pulse Biosciences, Inc. | $3.43B | Mid cap | +203.47% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
| PRGO | Perrigo Company plc | $2.05B | Mid cap | −36.05% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| BLFS | BioLife Solutions, Inc. | $1.82B | Small cap | +45.50% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% |
| SPTX | Seaport Therapeutics, Inc. | $1.49B | Small cap | +40.32% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| KALV | KalVista Pharmaceuticals Inc | $1.44B | Small cap | +98.68% |
| ANRO | Alto Neuroscience, Inc. | $1.43B | Small cap | +786.65% |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% |
| CRON.TO | Cronos Group Inc. | $1.31B | Small cap | +39.83% |
| CRON | Cronos Group Inc. | $1.31B | Small cap | +38.67% |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% |
| IMMX | Immix Biopharma, Inc. | $1.00B | Small cap | +617.86% |
| HELP | Cybin D/B/A Helus Pharma | $995.81M | Small cap | +77.71% |
| ACHV | Achieve Life Sciences, Inc. | $851.00M | Small cap | +177.52% |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% |
| ASMB | Assembly Biosciences, Inc. | $721.17M | Small cap | +36.81% |
| OABI | OmniAb, Inc. | $699.33M | Small cap | +198.76% |
| BHVN34.SA | BIOHAVEN LTDDRN | $694.68M | Small cap | −18.03% |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% |
| ICLR34.SA | ICON PLC DRN | $625.18M | Small cap | −14.33% |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% |
| SENS | Senseonics Holdings, Inc. | $493.84M | Small cap | +0.43% |
| SGHT | Sight Sciences, Inc. | $458.33M | Small cap | +97.87% |
| KSI.TO | kneat.com, inc. | $452.27M | Small cap | +19.93% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $449.94M | Small cap | −8.44% |
| MCTA | Charming Medical Limited | $445.55M | Small cap | +319.36% |
| CARL | Carlsmed, Inc. | $441.76M | Small cap | +16.40% |
| CCRN | Cross Country Healthcare Inc | $428.06M | Small cap | +0.38% |
| TBRG | TruBridge Inc | $393.58M | Small cap | +30.42% |
| E2NO34.SA | Enovis Corporation | $387.44M | Small cap | −19.24% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | $381.80M | Small cap | −33.79% |
| RCEL | AVITA Medical, Inc. | $327.52M | Small cap | +133.77% |
| SMTI | Sanara MedTech Inc. | $318.55M | Small cap | +2.09% |
| YDES | YD Bio Ltd | $307.41M | Small cap | −63.83% |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +225.53% |
| ACB | Aurora Cannabis Inc. | $253.24M | Small cap | −24.95% |
| ACB.TO | Aurora Cannabis Inc. | $252.71M | Small cap | −24.93% |
| CRDL | Cardiol Therapeutics Inc. | $250.00M | Small cap | +91.07% |
| CRDL.TO | Cardiol Therapeutics Inc. | $249.99M | Small cap | +90.38% |
| XLY.TO | Auxly Cannabis Group Inc. | $232.81M | Small cap | +1919.35% |
| NGEN | NervGen Pharma Corp. | $223.65M | Small cap | −8.30% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $218.56M | Small cap | +7.93% |
| ORMP | Oramed Pharmaceuticals Inc. | $218.55M | Small cap | +159.19% |
| XGN | Exagen Inc. | $185.81M | Small cap | −19.69% |
| SPRB | Spruce Biosciences, Inc. | $176.69M | Small cap | +721.93% |
| ASRT | Assertio Holdings Inc | $151.86M | Small cap | +103.46% |
| EMPG | Empro Group Inc | $143.05M | Small cap | +76.60% |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% |
| BMEA | Biomea Fusion, Inc. | $123.95M | Small cap | −8.06% |
| A2ZT34.SA | Azenta, Inc. | $120.48M | Small cap | +50.80% |
| LUNG | Pulmonx Corporation | $105.59M | Small cap | +34.41% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.